Go to the list of all blogs
Dem Sem's Avatar
published in Blogs
May 06, 2023
CDZIP pattern shows 8% price hike

CDZIP pattern shows 8% price hike

In the case of CDZIP, a bullish Triangle Symmetrical Top pattern has emerged on April 28, 2023, indicating that the market may be anticipating a potential price increase. Furthermore, the current confidence level to reach the target price is 72%, suggesting that market participants are fairly confident in the potential for the stock to rise.

The target price for CDZIP is $18.29, which represents an 8% increase from the breakout price of $17.17. This price target is based on the height of the triangle pattern, which is measured from the highest point of the triangle to the lowest point, and then projected upwards from the breakout point.

If the stock price breaks out above the upper trendline of the symmetrical triangle pattern, this would be considered a signal to enter the market with a long position, also known as the breakout price. In this case, the breakout price is $17.17. The distance to the target price is only 8%, making this a relatively low-risk opportunity for potential investors.

In conclusion, the Triangle Symmetrical Top pattern that has emerged for CDZIP is indicating a potential bullish trend in the near future. With a current confidence level of 72%, and a relatively short distance to the target price, this may be an attractive opportunity for investors looking for a potential increase in their investment returns. However, it is important to note that technical analysis is just one tool in the investor's toolbox and should be used in conjunction with other forms of analysis before making any investment decisions.

Related Ticker: CDZIP

Contributor

Dem Sem's AvatarDem Sem|Expert

CDZIP sees MACD Histogram crosses below signal line

CDZIP saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on August 14, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 49 instances where the indicator turned negative. In of the 49 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 26, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CDZIP as a result. In of 108 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

CDZIP moved below its 50-day moving average on August 26, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CDZIP crossed bearishly below the 50-day moving average on August 10, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CDZIP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CDZIP broke above its upper Bollinger Band on August 13, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CDZIP advanced for three days, in of 230 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 259 cases where CDZIP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (7.473). CDZIP has a moderately low P/E Ratio (0.000) as compared to the industry average of (26.236). CDZIP's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (2.723). CDZIP's Dividend Yield (0.101) is considerably higher than the industry average of (0.032). P/S Ratio (0.000) is also within normal values, averaging (6.226).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CDZIP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CDZIP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Industry description

Water utilities operate water treatment plants, and/or distribute water to residential and commercial customers. Companies operating in this industry are largely responsible for the safe and timely distribution of water. While most water systems are local or regional, some of the companies might have operations across several states. The industry is expected to be closely monitored by regulators for quality checks on the water being distributed. Investing in upgrading infrastructure is a major factor in bolstering the supply of clean/safe-to-use water. Given the absolute necessity of water in our lives, the industry is largely non-cyclical. American Water Works Company, Inc., Aqua America, Inc., American States Water Co. and California Water Service Group are some of the major water utilities companies in the U.S.

Market Cap

The average market capitalization across the Water Utilities Industry is 5.31B. The market cap for tickers in the group ranges from 41.88K to 27.47B. AWK holds the highest valuation in this group at 27.47B. The lowest valued company is AEPT at 41.88K.

High and low price notable news

The average weekly price growth across all stocks in the Water Utilities Industry was -1%. For the same Industry, the average monthly price growth was 7%, and the average quarterly price growth was 1%. CDZI experienced the highest price growth at 6%, while PCYO experienced the biggest fall at -5%.

Volume

The average weekly volume growth across all stocks in the Water Utilities Industry was -3%. For the same stocks of the Industry, the average monthly volume growth was 33% and the average quarterly volume growth was 16%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 70
P/E Growth Rating: 43
Price Growth Rating: 48
SMR Rating: 76
Profit Risk Rating: 86
Seasonality Score: -50 (-100 ... +100)
View a ticker or compare two or three
CDZIP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry WaterUtilities

Profile
Details
Industry
N/A
Address
550 South Hope Street
Phone
+1 213 271-1600
Employees
31
Web
https://www.cadizinc.com
Interact to see
Advertisement
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.
GDDY (GoDaddy) is down more than 17% today because its 2026 revenue outlook and near‑term sales guidance came in below Wall Street expectations, reinforcing worries about slowing growth and intense AI‑driven competition even though Q4 2025 headline results were solid.
For the first half of fiscal 2026, organic net sales and adjusted EPS both declined about 3% year over year and missed analyst expectations, with U.S. spirits and Chinese white spirits particularly weak. Management cut full‑year 2026 guidance again, now expecting organic sales to fall 2–3% and organic operating profit to be flat to up only low single digits, versus a prior outlook of flat to slightly down sales and low‑ to mid‑single‑digit profit growth.
DRVN (Driven Brands) is down more than 36% today because the company disclosed serious errors in its past financial statements, is delaying its Q4 2025 earnings release, and will have to restate results for the last two fiscal years, which shattered investor confidence and raised concerns about leverage and profitability.
Q4 2025 revenue was strong at about 257–258 million (up roughly 16% year over year and above forecasts), but adjusted EPS was 0.30 versus about 0.31–0.32 expected, and EBITDA of about 101–102 million was a touch below consensus.
Q4 2025 revenue was about 392 million, roughly 10–20% below consensus (around 430–440 million), and EPS came in at −0.44−0.44 versus forecasts near −0.27−0.27 to −0.32−0.32, a more than 60% negative surprise. Results were hit by a roughly 170 million non‑cash impairment plus weaker realized pricing and volumes, driving a large net loss in the quarter despite strong full‑year EBITDA and free cash flow.
AXON surged approximately +17.56% on February 25, 2026, closing at $520.18 versus the prior session's close of $442.51. The primary catalyst was a blowout Q4 2025 earnings report, with adjusted EPS of $2.15 crushing the consensus estimate of approximately $1.67.
CAVA shares surged approximately +25.01% on February 25, 2026, closing near $84.76, up from the prior session's close of $67.80. The primary catalyst was a better-than-expected Q4 fiscal 2025 earnings report, with EPS of $0.04 beating the $0.03 consensus estimate and revenue of ~$274.99M exceeding the $268.04M estimate.
ODD shares plunged approximately 49.21% on February 25, 2026, closing near $14.74, compared to the prior close of approximately $29.02. The primary catalyst was a shock Q1 2026 revenue warning: management guided for a roughly 30% year-over-year revenue decline due to a severe spike in customer acquisition costs (CAC).
MNKD shares collapsed 36.82% on February 25, 2026, closing at $3.50 versus the prior session's close of $5.54 — one of the largest single-day declines in the stock's recent history. The primary catalyst was United Therapeutics' surprise unveiling of Tresmi, a proprietary soft mist inhaler delivering treprostinil, announced during the company's Q4 2025 earnings call.
EOSE shares fell sharply on February 26, 2026, dropping approximately 31% from the prior session's close of $11.13 to around $7.64 in early trading, following a pre-market earnings release. Primary catalyst: Eos Energy reported Q4 2025 non-GAAP EPS of -$0.72, missing analyst consensus estimates by $0.48, a 200%+ negative surprise.
ARRY beat Q4 revenue expectations but showed a sharp year‑over‑year sales decline and a sizeable net loss. Adjusted EBITDA for Q4 badly missed Wall Street estimates, highlighting ongoing margin and cost pressures. 2026 guidance for EPS and EBITDA came in well below analyst forecasts, signaling weaker‑than‑hoped earnings power over the next year.
C3.ai (AI) dropped more than 18% today after delivering a deeply disappointing quarterly report, slashing its revenue outlook, and announcing mass layoffs, which together reinforced doubts about its growth story in an increasingly competitive AI software market.
On the surface, PRCT’s top line still grew: Q4 2025 revenue reached about 76.4 million dollars, up roughly 11.9–12% from the prior year. However, analysts had expected something closer to 94–96 million dollars, so the shortfall of nearly 20% was significant for a high‑growth med‑tech name.
Payoneer Global (PAYO) fell more than 18% today after it missed Wall Street expectations on both Q4 2025 revenue and earnings, and issued softer‑than‑hoped guidance that reinforced concerns about slowing growth and competitive pressure in cross‑border fintech.
Gold, uranium, and rare earth stocks are moving fast in 2026 — and this 15-minute AI Trading Agent is built to move faster. Designed for high-beta Mining & Metals leaders like NEM, LEU, MP, and KGC, it transforms commodity volatility into structured, data-driven opportunity with institutional-grade risk control.